View Featured Offers >>
64662
NF-κB Pathway Antibody Sampler Kit II
Primary Antibodies
Antibody Sampler Kit

NF-κB Pathway Antibody Sampler Kit II #64662

Reviews ()
Citations (0)
NF-κB Pathway Antibody Sampler Kit II: Image 1
Immunoprecipitation of IkBa from HeLa cell extracts. Lane 1 is 10% input, lane 2 is precipitated with Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, and lane 3 is IκBα (44D4) Rabbit mAb, #4812. Western blot was performed using IκBα (L35A5) Mouse mAb (Amino-terminal Antigen) #4814.
NF-κB Pathway Antibody Sampler Kit II: Image 2
Western blot analysis of extracts from various cell lines and rat spleen using NF-κB1 p105/p50 (D4P4D) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 3
CUT&RUN was performed with HeLa cells treated with human TNF-α #8902 (30 ng/ml, 1 hr) and NF-κB1 p105/p50 (D4P4D) Rabbit mAb, using CUT&RUN Assay Kit #86652. DNA Libraries were prepared using DNA Library Prep Kit for Illumina® (ChIP-seq, CUT&RUN) #56795. The figure shows binding across NFKBIA, a known target gene of NFkB (see additional figure containing CUT&RUN-qPCR data).
NF-κB Pathway Antibody Sampler Kit II: Image 4
Western blot analysis of extracts from THP-1 cells, differentiated with TPA (#9905, 80 nM for 24h) and treated with 1 μg/ml LPS for the indicated times, using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 5
Western blot analysis of extracts from various cell lines, untreated or treated with IFNa (#36000, 20 ng/mL, 5 min); using Phospho-IκBα (Ser32) (14D4) Rabbit mAb #2859 (upper), IκBα (L35A5) Mouse mAb (Amino-terminal Antigen) #4814 (middle), and β-Actin (D6A8) Rabbit mAb #8457 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 6
Western blot analysis of extracts from HeLa and NIH/3T3 cells, untreated or TNF-α treated (#2169, 20 ng/ml for 5 minutes), using Phospho-NF-κB p65 (Ser536) (93H1) Rabbit mAb (upper) or NF-κB p65 Antibody #3034 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 7
Western blot analysis of extracts from control HeLa cells (lane 1) or HeLa cells with an apparent in-frame truncation mutation in the gene encoding IκBα (lane 2) using IκBα (44D4) Rabbit mAb, #4812 (upper) or β-actin (13E5) Rabbit mAb #4970 (lower). The change in IκBα molecular weight in the mutated HeLa cells is consistent with an in-frame deletion.
NF-κB Pathway Antibody Sampler Kit II: Image 8
Western blot analysis of extracts from various cell lines using IKKα (D3W6N) Rabbit mAb (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 9
After the primary antibody is bound to the target protein, a complex with HRP-linked secondary antibody is formed. The LumiGLO® is added and emits light during enzyme catalyzed decomposition.
NF-κB Pathway Antibody Sampler Kit II: Image 10
Western blot analysis of extracts from various cell lines using NF-κB p65 (D14E12) XP® Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 11
Western blot analysis of extracts from various cell lines using IKKβ (D30C6) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 12
Western blot analysis of extracts from THP-1 cells differentiated with TPA (12-O-Tetradecanoylphorbol-13-Acetate) #4174 (50 ng/ml, 18 hr, and then rested 48 hr), either vehicle (-) or treated with Lipopolysaccharides (LPS) #14011 (5 μg/ml, 15 min; +), using Phospho-NF-κB p65 (Ser529) Antibody (upper), NF-κB p65 (D14E12) XP® Rabbit mAb #8242 (middle), and GAPDH (D16H11) XP® Rabbit mAb #5174 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 13
Western blot analysis of extracts from HeLa and NCI-H1299 cells, untreated (-) or treated with Human Tumor Necrosis Factor-α (hTNF-α) #8902 (20 ng/ml, 5 min; +), using Phospho-NF-κB p65 (Ser529) Antibody (upper), NF-κB p65 (D14E12) XP® Rabbit mAb #8242 (middle), and GAPDH (D16H11) XP® Rabbit mAb #5174 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 14
Immunoprecipitation of NF-κB1 p105/p50 from Raji cell extracts using Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (lane 2) or NF-κB1 (D4P4D) Rabbit mAb (lane 3). Lane 1 is 10% input. Western blot was performed using NF-κB1 p105/p50 (D4P4D) Rabbit mAb. Mouse Anti-rabbit IgG (Light-Chain Specific) (L57A3) mAb #3677 was used as a secondary antibody.
NF-κB Pathway Antibody Sampler Kit II: Image 15
CUT&RUN was performed with HeLa cells treated with human TNF-α #8902 (30 ng/ml, 1 hr) and NF-κB1 p105/p50 (D4P4D) Rabbit mAb, using CUT&RUN Assay Kit #86652. DNA Libraries were prepared using DNA Library Prep Kit for Illumina® (ChIP-seq, CUT&RUN) #56795. The figures show binding across chromosome 14 (upper), including NFKBIA (lower), a known target gene of NFkB (see additional figure containing CUT&RUN-qPCR data).
NF-κB Pathway Antibody Sampler Kit II: Image 16
Western blot analysis of extracts from HeLa cells, untreated or treated with TNFa (#16789, 20 ng/mL, 10 min) and Calyculin A (#9902, 100 nM, 10 min); THP-1 cells differentiated with TPA (#4174, 80 nM for 16hr) untreated and treated with LPS (#14011, 1 μg/ml for 1hr) using #2697 (upper) or IKKα (D3W6N) Rabbit mAb #61294, IKKβ (D30C6) Rabbit mAb #8943 (middle), and β-Actin (D6A8) Rabbit mAb #8457 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 17
Western blot analysis of extracts from THP-1 cells, differentiated with TPA (#9905, 80 nM for 24h) and treated with 1 μg/ml LPS for the indicated times, using Phospho-NF-κB p65 (Ser536) (93H1) Rabbit mAb (upper) and NF-κB p65 (C22B4) Rabbit mAb #4764 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 18
Western blot analysis of extracts from various cell lines using IκBα (44D4) Rabbit mAb #4812 (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 19
Immunoprecipitation of IKKα from HCT 116 cell extracts. Lane 1 is 10% input, lane 2 is Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, and lane 3 is IKKα (D3W6N) Rabbit mAb. Western blot was performed using IKKα (D3W6N) Rabbit mAb. Anti-Rabbit IgG, HRP-linked Antibody #7400 was used as secondary antibody.
NF-κB Pathway Antibody Sampler Kit II: Image 20
Western blot analysis of extracts from wild-type, IKKα (-/-), and IKKβ (-/-) mouse embryonic fibroblasts (MEFs) using IKKβ (D30C6) Rabbit mAb (upper) and GAPDH (14C10) Rabbit mAb #2118 (lower).
NF-κB Pathway Antibody Sampler Kit II: Image 21
Confocal immunofluorescent analysis of C2C12 cells, untreated (left) or treated with Mouse Tumor Necrosis Factor-α (mTNF-α) #5178 (20 ng/ml, 30 min; right), using NF-κB1 p105/p50 (D4P4D) Rabbit mAb (green). Actin filaments were labeled with DyLight 554 Phalloidin #13054 (red). Blue pseudocolor= DRAQ5® #4084 (fluorescent DNA dye).
NF-κB Pathway Antibody Sampler Kit II: Image 22
CUT&RUN was performed with HeLa cells treated with human TNF-α #8902 (30 ng/ml, 1 hr) and either NF-κB1 p105/p50 (D4P4D) Rabbit mAb or Rabbit (DA1E) mAb IgG XP® Isotype Control (CUT&RUN) #66362, using CUT&RUN Assay Kit #86652. The enriched DNA was quantified by real-time PCR using SimpleChIP® Human IκBα Promoter Primers #5552 and SimpleChIP® Human α Satellite Repeat Primers #4486. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
NF-κB Pathway Antibody Sampler Kit II: Image 23
Immunohistochemical analysis of paraffin-embedded human gall bladder (chronic cholecystitis), using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 24
Confocal immunofluorescent analysis of HeLa cells, serum starved (left) or TNF-α treated (#8902 at 20 ng/ml for 20 min, right), using Phospho-NF-κB p65 (Ser536) (93H1) Rabbit mAb (green). Actin filaments have been labeled with Alexa Fluor® phalloidin 555 (red).
NF-κB Pathway Antibody Sampler Kit II: Image 25
Immunohistochemical analysis using NF-κB p65 (D14E12) XP® Rabbit mAb on SignalSlide® NF-κB p65 IHC Controls #12873 (paraffin-embedded HCT116 cells, untreated (left) or treated with hTNF-α #8902 (right)).
NF-κB Pathway Antibody Sampler Kit II: Image 26
Flow cytometric analysis of NIH/3T3 cells using NF-κB1 p105/p50 (D4P4D) Rabbit mAb (solid line) compared to concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed line). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
NF-κB Pathway Antibody Sampler Kit II: Image 27
Immunohistochemical analysis of paraffin-embedded human colon carcinoma, untreated (left) or λ phosphatase-treated (right), using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 28
Flow cytometric analysis of HeLa cells, untreated (blue) or treated with Human Tumor Necrosis Factor-α (hTNF-α) #8902 and Calyculin A #9902 (20 ng/ml and 100 nM, 15 min; green), using Phospho-NF-κB p65 (Ser536) (93H1) Rabbit mAb (solid lines) or concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed lines). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
NF-κB Pathway Antibody Sampler Kit II: Image 29
Immunohistochemical analysis of paraffin-embedded human chronic cholecystitis using NF-κB p65 (D14E12) XP® Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 30
Immunohistochemical analysis of paraffin-embedded human colon carcinoma, showing cytoplasmic localization, using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 31
Confocal immunofluorescent analysis of HT-1080 cells, untreated (left) or treated with hTNF-α #8902 (20 ng/ml, 20 min) (right), using NF-κB p65 (D14E12) XP® Rabbit mAb (green). Actin filaments were labeled with DY-554 phalloidin (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
NF-κB Pathway Antibody Sampler Kit II: Image 32
Chromatin immunoprecipitations were performed with cross-linked chromatin from HeLa cells treated with Human Tumor Necrosis Factor-α (hTNF-α) #8902 (30 ng/ml, 1 hr) and either NF-κB1 p105/p50 (D4P4D) Rabbit mAb or Normal Rabbit IgG #2729 using SimpleChIP® Enzymatic Chromatin IP Kit (Magnetic Beads) #9003. The enriched DNA was quantified by real-time PCR using SimpleChIP® Human IκBα Promoter Primers #5552, human IL-8 promoter primers, and SimpleChIP® Human α Satellite Repeat Primers #4486. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
NF-κB Pathway Antibody Sampler Kit II: Image 33
Immunohistochemical analysis of paraffin-embedded human lung (chronic bronchitis), using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 34
Flow cytometric analysis of HeLa cells using NF-κB p65 (D14E12) XP® Rabbit mAb (blue) compared to concentration matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (red).
NF-κB Pathway Antibody Sampler Kit II: Image 35
Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb in the presence of control peptide (left) or Phospho-IKK-alpha/beta (Ser176/180) Blocking Peptide #1023 (right).
NF-κB Pathway Antibody Sampler Kit II: Image 36
Chromatin immunoprecipitations were performed with cross-linked chromatin from HeLa cells treated with hTNF-α #8902 (30 ng/ml, 1 hr) and NF-κB p65 (D14E12) XP® Rabbit mAb, using SimpleChIP® Enzymatic Chromatin IP Kit (Magnetic Beads) #9005. DNA Libraries were prepared using DNA Library Prep Kit for Illumina® (ChIP-seq, CUT&RUN) #56795. The figure shows binding across IL-8, a known target gene of NFκB (see additional figure containing ChIP-qPCR data). For additional ChIP-seq tracks, please download the product data sheet.
NF-κB Pathway Antibody Sampler Kit II: Image 37
Flow cytometric analysis of THP-1 cells, untreated (blue) and with TPA and LPS (green) using IKK-α (Ser176/Ser180) phosphate Rabbit mAb. Anti-rabbit IgG (H+L), F(ab')2 Fragment (PE Conjugate) #8885 was used as a secondary antibody.
NF-κB Pathway Antibody Sampler Kit II: Image 38
Chromatin immunoprecipitations were performed with cross-linked chromatin from HeLa cells treated with hTNF-α #8902 (30 ng/ml, 1 hr) and NF-κB p65 (D14E12) XP® Rabbit mAb, using SimpleChIP® Enzymatic Chromatin IP Kit (Magnetic Beads) #9005. DNA Libraries were prepared using DNA Library Prep Kit for Illumina® (ChIP-seq, CUT&RUN) #56795. The figure shows binding across chromosome 4 (upper), including IL-8 (lower), a known target gene of NFκB (see additional figure containing ChIP-qPCR data).
NF-κB Pathway Antibody Sampler Kit II: Image 39
Western blot analysis of extracts from TNF-alpha and Calyculin A treated HeLa and NIH/3T3 cells, using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb.
NF-κB Pathway Antibody Sampler Kit II: Image 40
Chromatin immunoprecipitations were performed with cross-linked chromatin from HeLa cells treated with hTNF-α #8902 (30 ng/ml, 1 hr) and either NF-κB p65 (D14E12) XP® Rabbit mAb or Normal Rabbit IgG #2729 using SimpleChIP® Enzymatic Chromatin IP Kit (Magnetic Beads) #9003. The enriched DNA was quantified by Real-Time PCR using SimpleChIP® Human IκBα Promoter Primers #5552, human IL-8 promoter primers, and SimpleChIP® Human α Satellite Repeat Primers #4486. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
NF-κB Pathway Antibody Sampler Kit II: Image 41
CUT&RUN was performed with HeLa cells treated with hTNF-α #8902 (30 ng/ml, 1 hr) and NF-κB p65 (D14E12) XP® Rabbit mAb, using CUT&RUN Assay Kit #86652. DNA Libraries were prepared using DNA Library Prep Kit for Illumina® (ChIP-seq, CUT&RUN) #56795. The figure shows binding across LAMC2, a known target gene of NF-κB p65 (see additional figure containing CUT&RUN-qPCR data).
NF-κB Pathway Antibody Sampler Kit II: Image 42
CUT&RUN was performed with HeLa cells treated with hTNF-α #8902 (30 ng/ml, 1 hr) and NF-κB p65 (D14E12) XP® Rabbit mAb, using CUT&RUN Assay Kit #86652. DNA Libraries were prepared using DNA Library Prep Kit for Illumina® (ChIP-seq, CUT&RUN) #56795. The figures show binding across chromosome 1 (upper), including LAMC2 (lower), a known target gene of NF-κB p65 (see additional figure containing CUT&RUN-qPCR data).
NF-κB Pathway Antibody Sampler Kit II: Image 43
CUT&RUN was performed with HeLa cells treated with hTNF-α #8902 (30 ng/ml, 1 hr) and either NF-κB p65 (D14E12) XP® Rabbit mAb or Rabbit (DA1E) mAb IgG XP® Isotype Control (CUT&RUN) #66362, using CUT&RUN Assay Kit #86652. The enriched DNA was quantified by real-time PCR using human LAMC2 upstream primers, and human ITM2A upstream primers. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
NF-κB Pathway Antibody Sampler Kit II: Image 44
Immunoprecipitation of NF-kB p65 from CHO cell extracts. Lane 1 is 10% input, lane 2 is precipitated with Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, and lane 3 is NF-κB p65 (D14E12) XP® Rabbit mAb, #8242. Western blot was performed using NF-κB p65 (L8F6) Mouse mAb, #6956.
To Purchase # 64662
Cat. # Size Qty. Price
64662T
1 Kit  (9 x 20 microliters)
$ 708

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
IKKα (D3W6N) Rabbit mAb 61294 20 µl
  • WB
  • IP
H M R 85 Rabbit IgG
IKKβ (D30C6) Rabbit mAb 8943 20 µl
  • WB
  • IP
H M R Mk 87 Rabbit IgG
Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb 2697 20 µl
  • WB
  • IHC
  • F
H M R Mk 85 IKK-alpha 87 IKK-beta Rabbit IgG
IκBα (44D4) Rabbit mAb 4812 20 µl
  • WB
  • IP
H M R Hm Mk Mi 39 Rabbit IgG
Phospho-IκBα (Ser32) (14D4) Rabbit mAb 2859 20 µl
  • WB
  • IP
H M R Mk 40 Rabbit IgG
NF-κB p65 (D14E12) XP® Rabbit mAb 8242 20 µl
  • WB
  • IP
  • IHC
  • IF
  • F
  • ChIP
  • C&R
H M R Hm Mk Dg 65 Rabbit IgG
Phospho-NF-κB p65 (Ser536) (93H1) Rabbit mAb 3033 20 µl
  • WB
  • IP
  • IF
  • F
H M R Hm Mk Pg 65 Rabbit IgG
NF-κB1 p105/p50 (D4P4D) Rabbit mAb 13586 20 µl
  • WB
  • IP
  • IF
  • F
  • ChIP
  • C&R
H M R 50 Active form. 120 Precursor Rabbit IgG
Phospho-NF-κB p65 (Ser529) Antibody 96874 20 µl
  • WB
H 65 Rabbit 
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
  • WB
Rab Goat 

Product Description

The NF-κB Pathway Antibody Sampler Kit II contains reagents to examine the activation state and total protein levels of key proteins in the NF-κB pathway: IKKα, IKKβ, NF-κB p65/RelA, and IκBα. The kit includes enough antibodies to perform two western blot experiments with each primary antibody.

Specificity / Sensitivity

Each antibody in the NF-κB Pathway Antibody Sampler Kit II detects endogenous levels of its target protein. IKKβ (D30C6) Rabbit mAb does not cross-react with other IKK family members. Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb detects IKKα only when phosphorylated at Ser176/180 and IKKβ only when phosphorylated at Ser177/181. Phospho-NF-κB p65 (Ser529) Antibody recognizes endogenous levels of NF-κB p65 protein only when phosphorylated at Ser529. Phospho-IκBα (Ser32) (14D4) Rabbit mAb detects endogenous levels of IκBα only when phosphorylated at Ser32. NF-κB p65 (D14E12) XP® Rabbit mAb does not cross-react with other NF-κB/Rel family members. Phospho-NF-κB p65 (Ser536) (93H1) Rabbit mAb detects NF-κB p65 only when phosphorylated at Ser536. It does not cross-react with the p50 subunit or other related proteins.

Source / Purification

Monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues near the carboxy termini of human IKKβ and IκBα, or residues surrounding Glu498 of human NF-κB p65/RelA, Ser176/180 of human IKKα, Ser32 of human IκBα, Ser536 of human NF-κB p65, Ser529 of human NF-κB p65, and Ile415 of mouse NF-κB1 p105/p50; with recombinant protein specific to a central region of human IKKα protein.

Background

The transcriptional nuclear factor κB (NF-κB)/Rel transcription factors are present in the cytosol in an inactive state, complexed with the inhibitory IκB proteins. Activation occurs via phosphorylation of IκBα at Ser32 and Ser36, resulting in the ubiquitin-mediated proteasome-dependent degradation of IκBα and the release and nuclear translocation of active NF-κB dimers. The regulation of IκBβ and IκBε is similar to that of IκBα, however, the phosphorylation and degradation of these proteins occurs with much slower kinetics. Phosphorylation of IκBβ occurs at Ser/Thr19 and Ser23, while IκBε can be phosphorylated at Ser18 and Ser22. The key regulatory step in this pathway involves activation of a high molecular weight IkappaB kinase (IKK) complex, consisting of three tightly associated IKK subunits. IKKα and IKKβ serve as the catalytic subunits of the kinase. Activation of IKK depends on phosphorylation at Ser177 and Ser181 in the activation loop of IKKβ (176 and 180 in IKKα). NF-κB-inducing kinase (NIK), TANK-binding kinase 1 (TBK1), and its homolog IKKε (IKKi), phosphorylate and activate IKKα and IKKβ.
The NF-κB family of transcription factors is comprised of five proteins in mammals, p65/RelA, c-Rel, RelB, NF-κB1 (p105/p50), and NF-κB2 (p100/p52). p105 and p100 are proteolytically processed to produce p50 and p52, respectively. The 50 kDa active form is produced through proteolytic processing following IKK-mediated phosphorylation of p105 at multiple sites (Ser922, 924, 928, and 933), while p100's processing to p52 is induced by phosphorylation of Ser864 and Ser868. The p50 and p52 products form dimeric complexes with Rel proteins, which are then able to bind DNA and regulate transcription. Phosphorylation of p65/RelA at Ser276 by PKA C and MSK1 enhances transcriptional activity. p65 phosphorylation at Ser536 regulates activation, nuclear localization, protein-protein interactions, and transcriptional activity. PMA-induced NF-κB transcriptional activity is dependent on the region of p65 containing the potential phosphorylation sites Ser457, Thr458, Thr464, and Ser468. Phosphorylation of Ser468 by GSK-3β inhibits basal p65 activity.
  1. Yamamoto, Y. and Gaynor, R.B. (2004) Trends Biochem. Sci. 29, 72-79.
  2. Ghosh, S. and Karin, M. (2002) Cell 109, S81-S96.
  3. Viatour, P. et al. (2005) Trends Biochem. Sci. 30, 43-52.
  4. Ho, C.M. et al. (2016) PLoS One 11, e0150339.
  5. Beyaz, S. et al. (2016) Nature 531, 53-8.

Pathways & Proteins

Explore pathways + proteins related to this product.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.